The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines", decided to abolish state registration and exclusion from stateRegister of medicinal products for the medical use of the medicinal product (registration certificate P N014280 / 01 dated December 1, 2009 issued by Sandoz Private Ltd., India):
Adelfan-Ezidreks (trade name of the medicinal product)
Reserpine + Dihydralazine +Hydrochlorothiazide (international non-proprietary or grouping or chemical name)
Tablets (dosage form, dosage)
Sandoz Private Limited, India Norli Mumbai, India (name and address of the location of the manufacturer of the medicinal product)
on the basis of filing an application by the authorized legal entity Novartis Pharma LLC to cancel the state registration of the medicinal product.